No Longer Accepting Claims
TorHoerman Law is no longer accepting claims for the Tepezza Lawsuit.
Intake Closed
The Tepezza Lawsuit claims that Horizon Therapeutics failed to properly warn patients and doctors about the risk of permanent hearing loss and other auditory side effects associated with the drug.
Plaintiffs allege that despite growing evidence linking Tepezza to serious hearing damage, the manufacturer continued to market it as a safe and effective treatment for Thyroid Eye Disease (TED) without adequate warnings.
On this page, we’ll discuss the Tepezza Lawsuit for hearing impairment and permanent hearing loss, how to file a Tepezza lawsuit, and much more.
Tepezza, a prescription drug for Thyroid Eye Disease (TED), has been linked to severe and potentially permanent hearing loss in some patients.
Tepezza Hearing Loss Claims against Horizon Therapeutics allege that the company failed to adequately warn users about these risks, despite growing evidence of hearing-related side effects.
Many individuals who took Tepezza report experiencing tinnitus, muffled hearing, and even total hearing loss after treatment.
As a result, the Tepezza litigation is underway, with cases consolidated in a multidistrict litigation (MDL) in the Northern District of Illinois.
Plaintiffs argue that Horizon neglected its duty to disclose the full extent of Tepezza’s risks, leaving patients vulnerable to life-altering complications.
Those affected may be eligible to seek compensation for medical expenses, lost wages, and the impact of their hearing loss on daily life.
Legal action is being strategized by our attorneys for Horizon Therapeutics’ failure to properly warn patients of potential hearing loss side effects.
You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.
Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.
The Tepezza hearing loss MDL added 4 cases between January and February, increasing from 273 to 277.
Filing activity remains measured as the litigation develops around ototoxicity allegations.
The court continues to manage coordinated discovery, with no new JPML actions reported during the month.
You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.
Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.
The Tepezza lawsuit showed no change in the total number of multidistrict litigation (MDL) cases from December 2025 to January 2026.
The docket remained at 273 total cases in both December 2025 and January 2026, with no new filings added during the month.
The Tepezza lawsuit involves claims that the thyroid eye disease drug Tepezza caused hearing-related injuries, including hearing loss and tinnitus.
Plaintiffs allege that the drug’s labeling failed to adequately warn about the risk of permanent auditory damage associated with Tepezza treatment.
You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.
Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.
The Tepezza lawsuit showed a slight increase in total multidistrict litigation (MDL) cases between November 2025 and December 2025.
The docket increased from 272 cases in November 2025 to 273 cases in December 2025, reflecting 1 new filing.
The Tepezza lawsuit involves allegations that the thyroid eye disease medication Tepezza caused hearing loss or tinnitus.
Plaintiffs claim that prescribing information did not adequately warn patients or healthcare providers about potential permanent or long-term auditory damage.
You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.
Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.
All deadlines for the upcoming Tepezza bellwether trials have been eliminated, indicating a possible push toward a global settlement in the hearing loss litigation.
On October 1, Chief Magistrate Judge M. David Weisman issued a docket entry canceling all deadlines related to the bellwether cases following an off-the-record discussion with counsel for both parties.
The order follows a year of required settlement negotiations overseen by U.S. District Judge Thomas Durkin, who has instructed the parties to meet quarterly in an effort to resolve the matter.
The bellwether program, established in November 2023, included four representative Tepezza hearing loss and tinnitus lawsuits that were scheduled to go to trial in June 2026.
The abrupt cancellation of these dates, without any rulings dismissing claims, has fueled speculation that settlement negotiations are progressing.
More than 270 lawsuits are pending in the Northern District of Illinois, where plaintiffs allege Horizon Therapeutics failed to warn about the risk of hearing damage associated with its thyroid eye disease drug, Tepezza.
The Court has scheduled the next status conference for January 8, 2026.
The number of pending Tepezza hearing loss cases remained the same between October and November, holding steady at 272 total filings.
No new cases were added during this period.
You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.
Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.
The federal judge overseeing the Tepezza hearing loss multidistrict litigation (MDL) has removed all upcoming deadlines for bellwether trials, prompting speculation that Horizon Therapeutics may be nearing a global settlement.
The Court has scheduled a status conference for January 8, 2026, to address case management and potential next steps.
Tepezza (teprotumumab-trbw) was approved by the U.S. Food and Drug Administration (FDA) in 2020 for the treatment of thyroid eye disease.
Shortly after its release, patients began reporting hearing loss and tinnitus, adverse effects not originally disclosed on the drug’s label.
The FDA later required updated label warnings in July 2023, instructing healthcare providers to monitor patients’ hearing during treatment.
Horizon Therapeutics faces more than 270 Tepezza Lawsuits, each alleging that the company failed to adequately research and warn about the risk of permanent hearing damage.
Plaintiffs claim they could have avoided these injuries had the manufacturer issued timely safety communications and included appropriate warnings before widespread prescription.
All federal Tepezza Lawsuits are consolidated in the Northern District of Illinois before U.S. District Judge Thomas Durkin.
The MDL was established to streamline discovery and pretrial proceedings involving similar claims of Tepezza-related hearing damage and tinnitus.
A bellwether program was initially created to test representative cases before juries, providing insight into how future trials might unfold. The first bellwether trial was set to begin in June 2026.
According to a docket entry dated October 1, Chief Magistrate Judge M. David Weisman held an off-the-record discussion with both parties’ counsel and subsequently struck all existing bellwether deadlines.
The Court’s decision follows nearly a year of required settlement discussions held every three months under Judge Durkin’s direction.
Although no official Tepezza settlement has been confirmed, the suspension of trial deadlines suggests the parties may be close to a resolution.
Between September and October, the Tepezza hearing loss lawsuit increased slightly from 270 to 272 pending cases.
The small increase in case count suggests filings have leveled off, but pretrial proceedings remain active as discovery continues.
The court is currently working through case-specific issues and ongoing coordination among parties.
You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.
Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.
The Tepezza hearing loss lawsuit added 10 new cases between September and August, rising from 260 cases to 270.
The 10 new filings reflect sustained interest in claims that Horizon failed to warn patients about the risk of irreversible hearing damage.
The MDL remains in the early discovery phase as both sides prepare for bellwether selection.
You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.
Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.
The Tepezza hearing loss lawsuit added 24 new cases between July and August, rising from 236 cases to 260.
The 24 new filings reflect sustained interest in claims that Horizon failed to warn patients about the risk of irreversible hearing damage.
The MDL remains in the early discovery phase as both sides prepare for bellwether selection.
You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.
Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.
U.S. District Judge Thomas Durkin has moved the start of the first Tepezza bellwether trial to June 8, 2026, granting plaintiffs a two-month extension to prepare expert testimony and trial evidence.
The revised schedule also moves the next three key trials to August 3, September 28, and November 30, 2026.
The new timeline reflects a July 7 case management order approving the extension, which the defendants did not oppose.
Depositions for the plaintiffs’ expert witnesses are scheduled between August 25 and September 19.
These landmark trials, each expected to last three to four weeks, will evaluate jury responses to claims that Horizon Therapeutics failed to warn patients about the risks of permanent hearing loss and tinnitus associated with Tepezza.
Over 230 federal cases are currently consolidated in the MDL, centered in the Northern District of Illinois.
Although non-binding, the results of these early trials are expected to significantly influence the direction of Tepezza settlement negotiations.
Judge Durkin has instructed attorneys to hold settlement discussions at least once every quarter.
A growing number of studies show that hearing loss from Tepezza (teprotumumab) treatment for thyroid eye disease can be subtle, delayed, or fall outside the range of standard audiometry—putting some patients at risk of undiagnosed impairment.
Why initial tests may miss loss:
Standard testing measures thresholds up to 8 kHz, but Tepezza-related losses often begin in higher frequencies.
Early signs—such as difficulty hearing in noisy environments or tinnitus—can go unnoticed in routine exams.
Recommendations for patients and doctors:
If patients report any new ear-related symptoms, providers should order advanced tests such as extended high-frequency audiometry and speech-in-noise exams for early detection
The multidistrict litigation (MDL) involving allegations that Tepezza caused permanent hearing loss and tinnitus has moved into the expert discovery phase, following the close of fact discovery on May 9, 2025.
The litigation is centralized in the U.S. District Court for the Northern District of Illinois before Judge Thomas Durkin.
As of June 2025, the MDL includes 221 pending cases.
Plaintiffs allege that Horizon Therapeutics, the maker of Tepezza (teprotumumab), failed to adequately warn users about risks of irreversible hearing damage.
The drug was approved by the FDA in 2020 to treat thyroid eye disease. In July 2023, the FDA updated the drug’s label to include a warning for potential permanent hearing loss.
The court has scheduled four bellwether trials in 2026, with trial dates set for April 6, June 1, July 27, and September 21.
These trials are intended to gauge how juries might respond to evidence and testimony that will be common across many claims.
Expert reports were submitted by June 9, 2025.
Depositions and admissibility challenges are expected over the coming months.
The outcome of the bellwether process will likely influence future settlement negotiations and the broader direction of the MDL.
The Tepezza hearing loss litigation added 4 new cases between May and June, increasing the MDL total to 221.
This modest rise follows recent activity around expert discovery, as both parties continue to prepare arguments related to the drug’s alleged ototoxicity.
Plaintiffs maintain that Horizon Therapeutics failed to warn about the risk of permanent hearing loss linked to Tepezza infusions for thyroid eye disease.
Upcoming motions are expected to address key scientific evidence, which could influence the pace and scope of future bellwether selections.
You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.
Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.
The Tepezza lawsuit involves claims that the thyroid eye disease drug Tepezza has caused permanent hearing loss and tinnitus in patients.
Plaintiffs allege that Horizon Therapeutics failed to adequately warn patients and doctors about the risk of auditory damage linked to the drug.
4 cases have been added to the Tepezza MDL in the past month.
17 cases have been added to the litigation since January 1st.
As more patients report unexpected hearing-related side effects, the number of lawsuits continues to rise.
You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.
Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.
In April 2025, the number of Tepezza Lawsuit filings increased to 213.
The new numbers reported by the JPML mark a rise of 6 cases compared to the 207 filings in March 2025.
This increase in Tepezza Lawsuits is reflective of ongoing awareness of potential injuries linked to Tepezza, a medication used to treat thyroid eye disease.
As the litigation continues to grow, more individuals may be coming forward with claims.
The uptick in filings highlights the growing impact of this lawsuit and the continuing efforts to address the legal concerns of those impacted by Tepezza.
You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.
Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.
In March 2025, the Tepezza litigation saw an increase in new filings, rising to 207 cases, a gain of 4 from the 203 cases recorded in February 2025.
February had seen a smaller increase of 3 cases compared to the previous month.
This steady growth indicates that the litigation continues to attract attention from individuals affected by the potential side effects of Tepezza, a drug used to treat thyroid eye disease.
As more plaintiffs come forward, the litigation provides individuals with the opportunity to seek compensation for their injuries related to the use of Tepezza.
You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.
Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.
In February 2025, the number of Tepezza Lawsuits increased to 203, reflecting a rise of 3 filings compared to the 200 cases in January 2025.
Plaintiffs allege that Tepezza has caused serious and permanent hearing loss, a side effect that was not sufficiently warned about by the manufacturer.
The relatively small rise in filings demonstrates that more individuals affected by the drug’s adverse effects are seeking legal recourse.
You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.
Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.
The Tepezza multidistrict litigation (MDL) is advancing toward its first bellwether trials, scheduled to begin in March 2026.
These early trials aim to assess jury responses to key evidence and arguments presented in lawsuits claiming that Horizon Therapeutics failed to warn users about the risk of irreversible hearing loss associated with Tepezza, a thyroid eye disease treatment.
The outcomes of these bellwether trials, while not binding on other claims, are expected to influence settlement negotiations significantly.
Average payouts awarded in these cases will serve as benchmarks for resolving remaining claims.
Judge Durkin has directed quarterly settlement discussions in an effort to resolve the litigation before trial.
However, if no agreement is reached following the bellwether trials, individual cases may be remanded to federal district courts nationwide for separate trials.
You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.
Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.
The number of Tepezza Lawsuits pending in the MDL has increased from 191 in December to 200 in January 2025, marking a rise of 9 new cases.
Tepezza, a medication used to treat thyroid eye disease, has been linked to hearing loss and other serious side effects, prompting ongoing legal action from those affected.
The increase in case filings highlights the growing number of individuals who have experienced adverse hearing-related effects after using Tepezza.
The lawsuits focus on allegations that the manufacturer, Horizon Therapeutics, failed to adequately warn patients about the potential risk of permanent hearing loss and other auditory issues.
You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.
Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.
The Judicial Panel on Multidistrict Litigation (JPML) reported 191 case filings for the Tepezza lawsuit in November.
In December, the number of case filings increased to 195, reflecting a growth of 4 cases.
The Tepezza Lawsuit involves claims that the drug, used for treating thyroid eye disease, has caused serious hearing-related side effects.
Plaintiffs argue that Horizon Therapeutics, the manufacturer, failed to properly warn patients and healthcare providers about the risks of hearing loss and tinnitus associated with Tepezza use.
Hearing loss and tinnitus can significantly affect daily life, making it difficult for those affected to maintain their quality of life and overall well-being.
You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.
Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.
A federal judge overseeing the Tepezza multidistrict litigation (MDL) has reprimanded both sides for improper conduct during depositions.
The litigation involves claims that Horizon Pharmaceuticals’ thyroid eye disease treatment, Tepezza, causes hearing loss.
Plaintiffs argue the company failed to disclose safety risks when seeking FDA approval and sold the drug despite knowledge of potential permanent harm.
In an order issued by U.S. Magistrate Judge M. David Weisman, requests for sanctions from both parties were denied.
Horizon accused plaintiffs’ counsel of canceling depositions without justification, while plaintiffs claimed Horizon’s legal team obstructed the process with overly aggressive objections.
Judge Weisman found fault with both sides, noting that each party incurred unnecessary costs due to the other’s actions.
The judge criticized plaintiffs’ attorneys for their approach during depositions, specifically for providing documents and calculations to assist witnesses in answering questions.
He also called out Horizon’s legal team for obstructive behavior, including inappropriate objections to foundational questions.
Judge Weisman warned that continued misconduct could result in reduced deposition time or even barring specific attorneys from further participation.
The MDL, centralized in the Northern District of Illinois, focuses on allegations that Tepezza was defectively designed and that Horizon failed to adequately warn about its risks.
The litigation highlights concerns about hearing loss linked to the drug, with plaintiffs seeking accountability for the alleged harm caused by the treatment.
You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.
Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.
The Tepezza Lawsuit involves claims that the drug, used for treating thyroid eye disease, has caused serious hearing-related side effects.
Plaintiffs argue that Horizon Therapeutics, the manufacturer, failed to properly warn patients and healthcare providers about the risks of hearing loss and tinnitus associated with Tepezza use.
In October, there were 178 cases filed in the Tepezza lawsuit, which increased slightly to 180 in November, adding 2 new cases.
Hearing loss and tinnitus can significantly affect daily life, making it difficult for those affected to maintain their quality of life and overall well-being.
You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.
Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.
The Tepezza Lawsuit focuses on claims that the drug, used to treat thyroid eye disease, can cause permanent hearing loss and other serious auditory issues.
Plaintiffs argue that the manufacturers of Tepezza failed to provide adequate warnings about the risk of hearing damage, leaving patients unaware of the potential long-term effects.
In September, the Judicial Panel on Multidistrict Litigation (JPML) reported 173 active Tepezza lawsuits.
By October, the number of cases had increased to 178, signaling the addition of five cases.
Patients who have used Tepezza report experiencing hearing loss, tinnitus, and other auditory issues, which can have lasting effects on their quality of life.
You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.
Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.
The Tepezza Lawsuit, which involves claims that the drug Tepezza has caused serious hearing loss and other auditory issues in patients, continues to see an increase in case filings.
In August 2024, there were 150 active cases in the Tepezza lawsuit.
By September 2024, this number has grown to 173.
The increase in case numbers suggests growing awareness among patients about the potential risks associated with Tepezza, a medication primarily used to treat thyroid eye disease.
Plaintiffs in this lawsuit allege that Horizon Therapeutics, the manufacturer of Tepezza, failed to provide adequate warnings about the risk of hearing damage, which has had a profound impact on their quality of life.
You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.
Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.
The Tepezza Hearing Loss lawsuit involves claims against Horizon Therapeutics regarding the thyroid eye disease drug Tepezza.
Plaintiffs allege that Tepezza causes hearing loss and other auditory issues.
In July, there were 138 filings in the Tepezza Hearing Loss lawsuit.
By August, this number increased to 150 filings.
The rise in filings indicates growing awareness of the potential hearing-related side effects of Tepezza, prompting more individuals to seek legal recourse.
Tepezza, intended for treating thyroid eye disease, has been reported to cause hearing loss and tinnitus in some patients.
These auditory issues can significantly impact quality of life, leading affected individuals to file lawsuits against Horizon Therapeutics for failing to adequately warn about these risks.
You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.
Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.
Horizon Therapeutics recently moved to dismiss several claims in the Tepezza hearing loss bellwether trials within the federal MDL.
The MDL includes about 140 product liability lawsuits, alleging that Tepezza, a thyroid eye disease treatment, causes permanent hearing damage.
Horizon Therapeutics contends that the FDA’s approval of Tepezza’s label in January 2020 should preempt these claims.
They argue that the label warnings, approved by the FDA, were sufficient, and plaintiffs have not presented “newly acquired information” to support their claims.
Horizon seeks dismissal of 11 bellwether claims for lacking plausible strict liability or negligent design defect arguments.
Nine claims are challenged on federal preemption grounds, and five are targeted for alleged fraudulent misrepresentation.
In the MDL, Judge Thomas Durkin oversees coordinated discovery and early trial dates, intended to assess jury responses to the evidence and testimony.
Twelve bellwether cases have been selected for early trials, with the first scheduled for March 2026.
If the court does not dismiss all bellwether claims, discovery will continue, and the initial group of 12 claims will be narrowed to four for trial dates set in March, May, June, and August 2026.
These trials will help gauge the strengths and weaknesses of the allegations that Horizon failed to warn about the risk of hearing loss and did not instruct doctors to perform hearing tests during treatment.
The results of these bellwether trials will significantly impact settlement discussions, and If no resolution is reached post-trials, individual cases may be remanded for separate trial dates across U.S. District Courts.
You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.
Contact TorHoerman Law for a free consultation today, or use the chatbot on this page to see if you qualify to file a Tepezza Lawsuit instantly.
These discussions aim to explore potential settlements and avoid numerous individual trials.
Horizon Therapeutics faces nearly 140 product liability claims alleging failure to warn users about the risk of hearing loss associated with Tepezza (teprotonumab-trbw), a treatment for thyroid eye disease.
The number of claims is expected to grow, potentially reaching several hundred before the first trials in March 2026.
In July 2023, the FDA updated Tepezza’s prescribing information to include warnings about severe and permanent hearing loss.
The new label advises doctors to assess patients’ hearing before, during, and after Tepezza infusions, plaintiffs argue that earlier warnings could have prevented their permanent hearing loss.
A multidistrict litigation (MDL) was established last year, centralizing Tepezza lawsuits before U.S. District Judge Thomas Durkin in the Northern District of Illinois.
A bellwether program will see 12 representative cases undergo case-specific discovery, with early trials helping to predict jury responses to evidence and testimony.
The first bellwether trial is set for March 9, 2026, with additional trials every two months.
Magistrate Judge M. David Weisman ordered the commencement of quarterly Tepezza settlement talks starting on or about August 1.
These mediation sessions aim to reach a global settlement agreement, resolving many or all claims.
The parties will meet at least once every 90 days.
Core fact discovery is set to close on December 20, 2024, with the first four bellwether cases proposed by January 17, 2025.
The outcomes of bellwether trials will influence Tepezza settlement negotiations, impacting the potential compensation Horizon may need to pay.
You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.
Contact TorHoerman Law for a free consultation today, or use the chatbot on this page to see if you qualify to file a Tepezza Lawsuit instantly.
The Tepezza Hearing Loss Lawsuit is ongoing, and our lawyers are still accepting cases from those affected by hearing loss linked to the thyroid eye disease drug Tepezza.
Tepezza Lawsuits involve claims of tinnitus, hearing loss, and other severe auditory problems resulting from the use of Tepezza.
The core arguments in the Tepezza Hearing Loss lawsuits involve:
Healthcare professionals recommend the following precautions for those using Tepezza:
You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.
Contact TorHoerman Law for a free consultation today, or use the chatbot on this page to see if you qualify to file a Tepezza Lawsuit instantly.
The Tepezza Hearing Loss lawsuit involves claims that the thyroid eye disease medication Tepezza causes significant hearing loss in patients.
This lawsuit seeks to hold the manufacturer accountable for not adequately warning users of this serious side effect.
In June, there were 120 Tepezza Hearing Loss lawsuit filings.
By July, this number increased to 138, reflecting growing awareness of the risks associated with Tepezza.
Tepezza can cause hearing loss by damaging auditory nerves and ear structures, leading to tinnitus and permanent deafness.
These health issues have led more individuals to join the Tepezza Hearing Loss lawsuit.
The Tepezza Hearing Loss lawsuit aims to hold the manufacturer responsible for the harm caused by the medication.
Affected individuals should consult a Tepezza hearing loss lawyer to explore their legal options.
You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.
Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.
Federal Tepezza hearing loss litigation is progressing towards its first series of bellwether trials, scheduled between March 9, 2026, and August 24, 2026.
These trials will play a crucial role in shaping potential jury responses and advancing settlement discussions regarding claims against Tepezza’s parent company, Horizon Therapeutics.
Allegations central to the lawsuit accuse the pharmaceutical company of failing to sufficiently warn users about the risks of permanent and irreversible hearing loss associated with Tepezza, a treatment for thyroid eye disease.
The decision to push these cases to trial follows a preparatory period where U.S. District Judge Thomas Durkin, overseeing the multidistrict litigation (MDL) in the Northern District of Illinois, established a bellwether process.
This process involves a selection of 12 representative cases to undergo detailed discovery in anticipation of these early trial dates.
A deadline has been set for December 20, 2024, to conclude fact discovery for the 12 selected cases.
If you or a loved one took Tepezza and has subsequently suffered hearing loss (permanent loss or partial loss), tinnitus, or other hearing damage, you may be eligible to file a Tepezza Lawsuit.
Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a Tepezza Lawsuit instantly.
According to the latest updates from the Judicial Panel on Multidistrict Litigation (JPML), there are currently 120 Tepezza lawsuits consolidated in the Tepezza MDL, with seven new cases added since May 1st.
An increasing number of patients are filing claims after experiencing severe side effects from Tepezza, a medication used to treat Thyroid Eye Disease.
These lawsuits highlight concerns about hearing loss and other serious side effects linked to Tepezza.
Plaintiffs allege that they were not sufficiently informed about the potential risks associated with the treatment, leading to severe and unexpected health issues.
If you or a loved one took Tepezza and has subsequently suffered hearing loss (permanent loss or partial loss), tinnitus, or other hearing damage, you may be eligible to file a Tepezza Lawsuit.
Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a Tepezza Lawsuit instantly.
Tepezza, used for treating Thyroid Eye Disease, has been linked to serious side effects, including hearing loss and tinnitus.
Horizon Therapeutics, the manufacturer, faces allegations of not adequately warning patients about the potential risks of hearing impairment associated with Tepezza.
Patients have reported sudden or gradual hearing loss after starting treatment with Tepezza, which, in some cases, has been irreversible.
Tepezza potentially reduces the blood flow to the auditory system, damaging the inner ear’s hair cells essential for hearing.
This vascular effect can impair hearing, sometimes severely or irreversibly.
Key evidence in Tepezza hearing loss cases includes medical documentation of hearing conditions before and after Tepezza administration, audiometric test results, and records of Tepezza dosage and treatment duration.
Our Tepezza Lawyers estimate that the average Tepezza settlement may range between $75,000 and over 200,000 depending on individual circumstances and the direction of the litigation as a whole.
If you or a loved one took Tepezza and has subsequently suffered hearing loss (permanent loss or partial loss), tinnitus, or other hearing damage, you may be eligible to file a Tepezza Lawsuit.
Contact TorHoerman Law for a free legal consultation, or use the chatbot on this page to see if you qualify to file a Tepezza Lawsuit instantly.
A total of 113 cases are pending in the Tepezza Marketing, Sales Practices, and Products Liability Litigation according to the most recent filings.
12 new cases were sent to the MDL in the past month.
The lawsuit claims that Tepezza causes serious side effects, including hearing loss and other auditory issues.
Tepezza is a treatment for thyroid eye disease.
Plaintiffs claim that Horizon Therapeutics, the manufacturer of Tepzza, failed to
adequately warn patients and healthcare providers about these potential risks.
If you or a loved one has suffered hearing loss or hearing as a result of Tepezza usage, contact us today for a free consultation.
You can also use the chatbot on this page for an instant case evaluation.
Per the most recent Judicial Panel on Multidistrict Litigation (JPML) filings, there are now 101 Tepezza lawsuits pending in the Tepezza MDL.
More and more patients are coming forward with claims of experiencing severe side effects after using Tepezza, a treatment for Thyroid Eye Disease.
Tepezza has been linked to hearing loss and other significant side effects, and has led to growing concerns among patients who have undergone treatment with this medication.
Tepezza Lawsuits claim that patients were not adequately warned about the potential risks associated with Tepezza, leading to unexpected and severe health complications.
For individuals who have used Tepezza and are now facing health issues, it’s important to consider seeking the help of a lawyer.
Please reach out to our law firm for a free consultation.
You can also use the chatbot on this page for a free case evaluation and to find out if you qualify for the Tepezza Lawsuit.
117 Tepezza Lawsuits were added to the MDL in the past month, growing from 8,217 (reported on Feb. 1) to 8,334 (reported on Mar. 1).
This spike in the number of Tepezza cases is reflective of the growing concern regarding potential harmful side effects associated with the use of the drug, which is used in the treatment of Thyroid Eye Disease (TED).
The Judicial Panel on Multidistrict Litigation (JPML) is closely monitoring this surge in legal actions against Horizon Therapeutics, the manufacturer of Tepezza.
The plaintiffs in the Tepezza Lawsuit allege that the company failed to adequately warn patients and healthcare providers about the possible risks and adverse effects of the drug, including hearing loss.
If you or a loved one have experienced any adverse effects after taking Tepezza, you may be eligible to participate in the Tepezza lawsuit.
For more information and a free consultation, contact TorHoerman Law.
You can also use the chatbot on this page for immediate assistance and to determine if you qualify for this lawsuit.
As of February 2024, there are a total of 74 Tepezza Lawsuits pending according to the most recent JPML filings.
Tepezza Lawsuits are being consolidated into multidistrict litigation (MDL) under MDL 3079: Tepezza Marketing, Sales Practices, and Products Liability Litigation.
MDLs are legal procedures in the United States designed to handle multiple related civil lawsuits that involve similar issues, facts, or defendants.
When numerous individuals or entities file lawsuits related to a common set of circumstances, such as hearing loss resulting from Tepezza, these cases can be consolidated into a single federal district court for pretrial proceedings.
MDLs aim to streamline the litigation process by centralizing the discovery process, reducing duplication of efforts, and ensuring consistent rulings on key legal issues.
If you or a loved one used Tepezza and developed permanent hearing loss or other health problems, you may be eligible to file a Tepezza Lawsuit.
Contact us for a free consultation or use the chatbot on this page to find out if you qualify for the Tepezza Lawsuit instantly.
Currently, there are a total of 74 filings in the Tepezza Marketing, Sales Practices, and Products Liability Litigation, according to the most recent JPML filings published on January 2nd.
Tepezza Lawsuits for hearing loss are being consolidated into multidistrict litigation (MDL).
When numerous individuals have been injured in similar ways by the same product, drug, or accident, these cases can be consolidated into a single federal district court for pretrial proceedings.
MDLs aim to streamline the litigation process by centralizing the discovery process, reducing duplication of efforts, and ensuring consistent rulings on key legal issues.
Individuals who have developed hearing loss after using Tepezza are filing lawsuits, and the MDL offers a structured pathway to seek justice and compensation.
If you or a loved one used Tepezza and developed permanent hearing loss or other health problems, you may be eligible to file a Tepezza Lawsuit.
Contact us for a free consultation or use the chatbot on this page to find out if you qualify for the Tepezza Lawsuit instantly.
Defendant Horizon Therapeutics USA, Inc. moved to dismiss Plaintiff Cynthia Williams’s complaint, arguing preemption under Federal Rule of Civil Procedure 12(b)(6).
The core issue was whether the pre-approval design defect claims are preempted by federal law.
Williams alleged that her hearing loss and tinnitus were due to the drug’s design.
The Court ruled that Williams’s pre-approval design defect claims are not preempted, stating that Horizon could have designed a safer product before seeking FDA approval without conflicting with federal requirements.
The Court found that Horizon had control over the drug’s design before seeking FDA approval, indicating no conflict between federal and state laws.
The decision to dismiss Williams’s post-approval design defect claims was granted, but pre-approval claims were not dismissed on preemption grounds.
The Court indicated that whether Williams’s design defect claims warrant dismissal on other grounds was not addressed in this opinion.
The Court also highlighted that the debate over the application of Virginia or Illinois law is irrelevant to the preemption argument because federal law did not dictate the drug’s design before seeking FDA approval.
The decision referenced similar cases where pre-approval design defect claims were not preempted and contrasted a Sixth Circuit decision that had different conclusions, indicating reasons why it found them unpersuasive.
The Court emphasized that the argument presented by Horizon, stating the biologic drug Tepezza was incapable of redesign, requires further examination through discovery and was separate from the preemption question.
In essence, the Court allowed the pre-approval design defect claims to proceed, reasoning that the defendant had control over the drug’s design before seeking FDA approval and could have designed a safer product without violating federal regulations.
The ruling favored Williams in allowing her pre-approval design defect claims to move forward while dismissing the post-approval claims.
If you or a loved one used Tepezza and developed permanent hearing loss or other health problems, you may be eligible to file a Tepezza Lawsuit.
Contact us for a free consultation or use the chatbot on this page to find out if you qualify for the Tepezza Lawsuit instantly.
An important status conference within the Tepezza MDL, that was originally scheduled for October 12th, has now been rescheduled to October 19th, 2023.
During this conference, Judge Durkin is anticipated to provide guidance on electronic discovery procedures and address initial disputes among the parties concerning discovery regulations.
All legal representatives have been mandated to be present at the hearing in person.
If you or a loved one used Tepezza and developed permanent hearing loss or other health problems, you may be eligible to file a Tepezza Lawsuit.
Contact us for a free consultation or use the chatbot on this page to find out if you qualify for the Tepezza Lawsuit instantly.
A multidistrict litigation (MDL) for hearing loss claims related to Tepezza was established to manage multiple lawsuits sharing common questions of fact and law.
Tepezza Lawsuits have been consolidated in the US District Court for the Northern District of Illinois under the jurisdiction of U.S. District Judge Thomas Durkin.
The objective of the Tepezza MDL is to enhance the efficiency of legal proceedings by coordinating discovery and pretrial processes.
Judge Durkin plans to initiate a “bellwether” program, wherein a select group of representative cases will undergo targeted discovery in preparation for early trial dates.
This strategy aims to aid the parties in anticipating how juries might respond to recurring evidence and testimonies presented across the various cases involved in the litigation.
If you or a loved one were administered Tepezza infusions and subsequently suffered hearing loss or other hearing problems, you may be eligible to file a Tepezza Lawsuit.
Contact TorHoerman Law for a free consultation.
You can also use the chatbot on this page for a free and instant case evaluation.
The Tepezza lawsuit has been consolidated, and the judge presiding over the Tepezza MDL has designated the attorneys who will serve on the Plaintiffs’ Co-Lead Counsel, the Plaintiffs’ Liaison Counsel, and the Plaintiffs’ Executive Committee (PEC).
The PEC helps to oversee the litigation from the plaintiff side, advocating for the best interests of the plaintiffs involved.
The leading attorneys in the Tepezza Lawsuit coordinate their efforts and make it their goal to reach a successful outcome for those affected by hearing loss due to Tepezza infusions.
If you or a loved one were administered Tepezza infusions and subsequently suffered hearing loss or other hearing problems, you may be eligible to file a Tepezza Lawsuit.
Contact TorHoerman Law for a free consultation.
You can also use the chatbot on this page for a free and instant case evaluation.
As there have been talks about consolidating the lawsuit into a MDL, plaintiffs have advocated for the lawsuit to be centralized in either California’s northern district or Illinois’s northern district.
On June 2nd, the Judicial Panel on Multidistrict Litigation (JPML) decided that the lawsuit should be centralized in Illinois’s northern district, citing that this location will be most convenient for all parties and witnesses and will promote efficient conduct of the litigation.
This district is where the defendant, Horizon Therapeutics, is based.
The defendant Horizon opposes the consolidation of the litigation into a MDL, but the JPML justified this consolidation because all of the plaintiff’s have suffered the same specific injuries after taking the drug Tepezza.
The JPML also said consolidation will help streamline the litigation process and prevent inefficient arrangements and inconsistent rulings.
If you or a loved one were administered Tepezza infusions and subsequently developed hearing loss, tinnitus, or other hearing-related health problems, you may be eligible to file a Tepezza Lawsuit.
Contact TorHoerman Law for a free consultation.
You can also use the chatbot on this page to find out if you qualify for a Tepezza Lawsuit instantly.
Our Tepezza Lawyers are speaking to potential clients and assessing their eligibility.
In news surrounding Tepezza’s manufacturer (Horizon Therapeutics), the Federal Trade Commission (FTC) has filed a lawsuit to prevent Amgen’s $27.8 billion acquisition of Horizon Therapeutics, which would give Amgen a monopoly over the treatment of certain conditions.
The FTC argues that Amgen’s control of Horizon’s drugs, including Tepezza for thyroid eye disease and Krystexxa for chronic refractory gout, would significantly reduce competition in those markets.
The lawsuit was filed in response to the announced deal between the companies, and the FTC seeks a temporary restraining order and preliminary injunction to halt the sale.
The FTC is concerned about Amgen’s expanding reach and dominance in the pharmaceutical industry, potentially leading to increased control over pricing through multi-product contracts and bundling.
Visit this page for more updates on the Tepezza Lawsuit as they become available.
If you or a loved one were administered Tepezza infusions and subsequently developed hearing loss, tinnitus, or other hearing-related health problems, you may be eligible to file a Tepezza Lawsuit.
Contact TorHoerman Law for a free consultation.
You can also use the chatbot on this page to find out if you qualify for a Tepezza Lawsuit instantly.
The Judicial Panel for Multidistrict Litigation (JPML) is considering whether to consolidate Tepezza Lawsuits into multidistrict litigation.
The hearing for determining whether the Tepezza Lawsuit should be centralized into multidistrict litigation will take place on May 25th, 2023.
Multidistrict litigation, commonly referred to as MDL, is a special federal legal procedure designed to speed the process of handling complex litigations by consolidating cases and addressing all pretrial procedures in one court.
When a large number of people who have all been affected by the same thing file individual lawsuits, such as with Tepezza and hearing damage claims, the federal court system allows for the consolidation of these cases into an MDL to make them easier to manage.
MDLs take cases from multiple federal districts (each state has at least one district), and puts them into one district court.
This single district court, and one judge, then address all the discovery and pretrial procedures that apply to every case – cutting the costs and amount of resources needed, and keeping court rulings consistent with similar cases.
The consolidation of Tepezza Lawsuits into an MDL could be a major and welcomed development to lawyers and their clients.
Visit this page for more updates on the Tepezza Lawsuit as they become available.
If you or a loved one were administered Tepezza infusions and subsequently developed hearing loss, tinnitus, or other hearing-related health problems, you may be eligible to file a Tepezza Lawsuit.
Contact TorHoerman Law for a free consultation.
You can also use the chatbot on this page to find out if you qualify for a Tepezza Lawsuit instantly.
The investigation into Tepezza Lawsuit claims is still ongoing and our Tepezza Lawyers are meeting with prospective clients about the hearing loss side effects of the TED medication.
Despite legal action over the dangers of Tepezza, Horizon Therapeutics received FDA approval on new wording that enables more people on the thyroid eye disease (TED) spectrum to be prescribed the drug.
If you or a loved one were administered Tepezza infusions for Thyroid Eye Disease (TED) or a related condition and subsequently suffered hearing loss or other side effects, you may be eligible for a Tepezza Lawsuit.
Contact TorHoerman Law for a free consultation, or use the instant case evaluator on this page to see if you qualify for a Tepezza Lawsuit in under two minutes.
The Tepezza Lawsuit investigation is ongoing.
Several Tepezza lawsuits have been filed in state courts across the country.
Our law firm is meeting with potential clients about Tepezza hearing loss claims, and we are thoroughly investigating the dangers of this drug.
If you or a loved one were administered Tepezza infusions for Thyroid Eye Disease (TED) or a related condition and subsequently suffered hearing loss or other side effects, you may be eligible for a Tepezza Lawsuit.
Contact TorHoerman Law for a free consultation, or use the instant case evaluator on this page to see if you qualify for a Tepezza Lawsuit in under two minutes.
Our lawyers are investigating potential Tepezza lawsuits and meeting with people who have suffered hearing loss after being administered the drug.
If you or a loved one have suffered hearing loss or other related hearing problems after being administered Tepezza infusions, you may be eligible to file a legal claim.
Contact TorHoerman Law for a free consultation.
You can also use the chatbot on this page to see if you qualify for a Tepezza Hearing Loss Lawsuit.
We’re here to help.
At least ten (10) individuals who have suffered hearing loss from Tepezza have had their cases included in a motion filed in in the U.S. District Court for the Northern District of Illinois, and asking the court to consolidate the hearing loss lawsuits before one judge.
Horizon Therapeutics, the maker of Tepezza, has been accused of knowing about hearing loss risks of Tepezza, yet failing to warn about the importance of monitoring during treatment.
It is expected that more Tepezza lawsuits will be filed in the coming months, as former users discover that their hearing loss was caused by the thyroid eye disease infusion.
Horizon has objected to the call to consolidate Tepezza hearing loss lawsuits, claiming the cases will be too different to benefit from pretrial coordination.
Contact our law firm for a free consultation.
You can also use the chatbot on this page to find out whether you qualify for a Tepezza Lawsuit instantly.
Tepezza is a drug used to treat Thyroid Eye Disease (TED), produced by drug manufacturer Horizon Therapeutics.
Tepezza’s “mechanism of action” is to block IGF-1R, a protein found on the surface of human cells and a key driver of Thyroid Eye Disease (TED).
By doing so, symptoms of TED are reduced, such as swelling, inflammation, double vision, blurred vision and other vision problems.
Despite its intended benefits as a thyroid eye disease treatment, reports soon emerged that Tepezza was linked to serious hearing loss in some patients.
Research suggests that blocking IGF-1R may also interfere with auditory functions, leading to conditions such as tinnitus, muffled hearing, and, in some cases, permanent hearing impairment.
Plaintiffs in the Tepezza Hearing Loss Lawsuit allege that Horizon Therapeutics failed to adequately warn patients about these risks, leaving many to suffer unexpected and life-altering side effects.
Some individuals have developed permanent hearing loss after completing Tepezza treatments, impacting their ability to work, communicate, and engage in daily activities.
Those who experienced serious hearing loss after taking Tepezza may be eligible to seek compensation for medical costs, lost wages, and diminished quality of life.
If you’ve taken Tepezza and subsequently suffered hearing loss, you may be eligible to file a Tepezza Lawsuit and seek financial compensation.
Contact TorHoerman Law for a free consultation.
You can also use the chat feature on this page for a free case evaluation to find out if you’re eligible to file a Tepezza Lawsuit instantly.
No, there is currently no Tepezza class action lawsuit. Instead, individual Tepezza cases have been grouped into a multidistrict litigation (MDL) in the Northern District of Illinois.
The MDL legal process is used to consolidate Tepezza lawsuits that share similar claims—such as allegations that Horizon Therapeutics failed to warn about the risk of Tepezza-related hearing loss—while still allowing each plaintiff to pursue their own case.
Unlike a class action, where all plaintiffs are treated as a single group and receive equal compensation, multidistrict litigation (MDL) allows for individualized outcomes based on the specific details of each case.
This means that while pretrial proceedings, discovery, and expert testimony are handled collectively, each lawsuit can result in different settlements or verdicts depending on the severity of the plaintiff’s hearing loss and other damages.
Plaintiffs in the Tepezza MDL claim that Horizon Therapeutics knew or should have known about the risk of permanent hearing impairment but failed to properly warn patients and doctors.
If the MDL results in favorable rulings for plaintiffs, individual settlements or jury verdicts will be determined on a case-by-case basis.
Those affected by Tepezza-related hearing loss can still file claims and have their cases considered as part of the ongoing litigation.
Hearing Loss Lawsuits involving the medication Tepezza may be resolved through settlement negotiations with the drug manufacturer.
Tepezza Lawyers estimate that the average Tepezza settlement may range between $75,000 and over $200,000 depending on factors present in an individual’s case.
Factors that may influence a Tepezza settlement can include:
These Tepezza payout projections are by no means a guarantee of compensation in the Tepezza Lawsuit, they are merely estimations based on settlements in mass tort lawsuits involving dangerous medications.
Contact a Tepezza Lawyer from TorHoerman Law today for insight on your case and legal options.
You can use the chatbot on this page for a free and instant case evaluation, and to get in touch with our Tepezza Attorneys today.
The Tepezza MDL continues to grow, with over 270 pending Tepezza Lawsuits filed.
New Tepezza Lawsuits are currently being filed by lawyers across the country.
If you or a loved one took Tepezza and has susbequently suffered hearing loss (permanent loss or partial loss), tinnitus, or other hearing damage, you may be eligible to file a Tepezza Lawsuit.
Contact TorHoerman Law for a free legal consultation, or use the chatbot on this page to see if you qualify to file a Tepezza Lawsuit instantly.
Research studies have found that a shocking percentage of patients who received Tepezza infusions suffered from hearing loss, tinnitus and other hearing problems.
Initial studies found that hearing related side effects only impacted around 10% of those who received Tepezza infusions.
In more recent studies, such as one published by the Endocrine Society, up to 65% of patients experienced hearing loss or hearing problems.
The hearing problems suffered by Tepezza patients are serious:
“Of the 17 patients with new hearing symptoms, four had new or worsening sensorineural hearing loss, a type of hearing loss resulting from damaged hair cells in the inner ear. Three patients had patulous eustachian tube, a disorder in which the channel that runs between the middle ear and back of the nose and throat stays open. Normally, these eustachian tubes remain closed and open only occasionally to regulate air pressure around the ear drum. After three months, symptoms of patulous eustachian tube improved, but did not completely disappear. Two patients with sensorineural hearing loss had improvement in symptoms at one and six months.”
If you or a loved one took Tepezza to treat Thyroid Eye Disease and subsequently suffered from hearing related side effects, you may be eligible to file a claim.
If you do qualify for a Tepezza Lawsuit, there are some steps our legal team recommends taking.
These steps include gathering evidence and assessing damages, both of which an experienced dangerous drug attorney can help you with.
Your Tepezza Lawyer will also guide you through the civil lawsuit process entirely.
Evidence is extremely important in dangerous drug lawsuits.
Lawsuits are won and lost based on the quality of evidence available, so it’s important that you retain all relevant documentation pertaining to your potential Tepezza lawsuit.
Evidence in Tepezza Lawsuits may include:
Damages refer to the total economic and non-economic losses incurred as a result of an injury.
In Tepezza hearing loss lawsuits, damages may include the following:
TorHoerman Law is investigating the Tepezza Hearing Loss Case and working to secure financial compensation for those who have suffered hearing-related side effects from the drug.
Our law firm has decades of experience handling dangerous drug lawsuits and representing victims who have been injured through no fault of their own.
If you or a loved one took Tepezza and has susbequently suffered hearing loss (permanent loss or partial loss), persistent subjective hearing loss, tinnitus, or other hearing damage, you may be eligible to file a Tepezza Lawsuit.
Contact TorHoerman Law for a free legal consultation, or use the chatbot on this page to see if you qualify to file a Tepezza Lawsuit instantly.
Our goal is to hold Horizon Pharmaceuticals liable for any hearing related problems suffered by users of the drug and seek financial compensation for victims who have suffered.
Tor Hoerman has represented injured individuals for more than 30 years, with experience spanning individual personal injury cases and nationwide mass tort litigation. His work includes car accidents, catastrophic injuries, product liability claims, and other serious injury cases. Tor has served in court-appointed leadership roles in national litigation and tried cases involving major corporate defendants.
TorHoerman Law’s legal content is researched and written by our editorial team and attorneys for legal accuracy, clarity, and relevance. We rely on statutes, court records, government publications, medical research, and other authoritative sources when applicable. This page provides general legal information and does not constitute legal advice.
TorHoerman Law reviews its legal content for factual accuracy, current information, and relevant legal context before publication and as material developments occur. This article is provided for general informational purposes and does not constitute legal advice. For guidance about a specific case, contact TorHoerman Law.
You can learn more about this topic by visiting any of our Tepezza Lawsuit pages listed below:
A serious injury can change your life.
TorHoerman Law represents people whose lives have been disrupted by serious injuries, unsafe products, and negligence. Our attorneys handle individual personal injury cases as well as national mass tort lawsuits involving major corporations.
Founded in 2009, our legal team brings more than 100 years of combined experience handling serious injury and complex civil litigation.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
In this case, we obtained a verdict of $495 Million for our client’s child who was diagnosed with Necrotizing Enterocolitis after consuming baby formula manufactured by Abbott Laboratories.
In this case, we were able to successfully recover $20 Million for our client after they suffered a Toxic Tort Injury due to chemical exposure.
In this case, we were able to successfully recover $103.8 Million for our client after they suffered a COX-2 Inhibitors Injury.
In this case, we were able to successfully recover $4 Million for our client after they suffered a Traumatic Brain Injury while at daycare.
In this case, we were able to successfully recover $2.8 Million for our client after they suffered an injury due to a Defective Heart Device.
A serious injury can change your life.